PANVAS-40 is a proton pump inhibitor (PPI) containing Pantoprazole, which is used to reduce stomach acid production. It is commonly prescribed for the treatment of acid-related gastrointestinal disorders and provides relief from symptoms such as heartburn, acid reflux, and gastric ulcers.
Route of Administration: Oral tablet.
Typical Dose for Adults: One 40mg tablet once daily, typically 30 minutes before a meal.
Administration: Swallow the tablet whole with water. Do not crush, chew, or split the tablet.
Duration of Therapy: Usually prescribed for 4-8 weeks, depending on the condition being treated. For long-term therapy, follow the guidance of a healthcare provider.
Hypersensitivity: Avoid use in patients with known hypersensitivity to Pantoprazole or other PPIs.
Pregnancy and Breastfeeding: Consult a healthcare provider before use during pregnancy and breastfeeding.
Liver Disease: Use cautiously in patients with liver impairment; dose adjustments may be necessary.
Prolonged Use: Long-term use of PPIs may lead to vitamin B12 deficiency, magnesium deficiency, and an increased risk of bone fractures. Regular monitoring may be required.
Drug Interactions: Pantoprazole may interfere with the absorption of certain medications that require acidic conditions, such as ketoconazole or iron supplements.
Effective Acid Control: Reduces stomach acid production, providing relief from heartburn and acid reflux.
Promotes Healing: Helps heal erosive esophagitis and stomach ulcers.
Improves Quality of Life: Eases symptoms associated with GERD and other acid-related disorders.
Well-Tolerated: Minimal side effects when taken as prescribed.
Versatile Use: Suitable for the treatment of various gastrointestinal conditions involving excess acid production.